Ming‐Chih Liu
National Taiwan University Hospital(TW)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Vascular Tumors and Angiosarcomas, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution(2013)82 cited
- → Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression(2013)58 cited
- → Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in de novo acute myeloid leukemia patients(2018)40 cited
- → Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma(2004)38 cited
- → Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia(2023)37 cited
- → SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution(2014)33 cited
- → IPSS‐R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk‐stratify the patients(2014)18 cited
- → Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients(2022)17 cited
- → Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification(2023)13 cited
- → The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression(2014)13 cited